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Objectives. This study sought o determine whether myocardial 
contrast echocardiography could be used to detect and quantitate 
collateral blood flow capable of limiting the e~'ects ofischemia in 
an experimental modal of coronary thrombosis and reperfusion. 
Background. Myocardial contrast echocardiography has been 
used to assess collateral blood flow in humans, but this technique 
has not been extensively validated in the experimental l boratory. 
Methods. Myocardial ischemia occurred after electrically in- 
ducod left circumflex coronary artery thrombosis in a canine 
model. Ischemia was intensified by administration f vasodilators. 
Reperfusion was induced with recombinant tissue-type plasm~a,~- 
gen activator. Myocardial perfusion was assessed with contrast 
echocardiography and radiolabeled microspheres. Infarct size was 
determined by histocbe.mical staining methods. Myocardial sam- 
ples were evaluated histologically. 
Results. The dogs were classified into two groups on the basis of 
contrast echecardiographie detection of perfusion in the ischemic 
region: those with (n = 13) and without collateral f ow (n = 10). 
Collateral perfusion detected by contrast echocardiography ar- 
aUeled chaages detected by radiolabded microspheres during 
thrombosis and vasodilator administration. A 91% agreement was 
observed between the two techniques in detecting collateral f ow 
>0.3 mi/min per g (p < 0.0001). Collateral perfusion correlated 
directly with radial shortening fractions of the ischemic myocar- 
d~,um (p < 0.01). Recovery offunction after epecfusion was faster, 
infarct size was smaller (mean [±SD] 4 ± 1% vs. 11 ± 3%, p = 
0.05), and histopathologic injury v, as less in dogs with than 
without collateral flow, respectively (p < 0.05). 
Condusions. Myocardial contrast echocardiography can iden- 
tify physiologically significant collateral vessels capable of limit- 
ing the degree of ischemic damage during coronary thrombosis. 
The magnitude of collateral f ow and the change in flow induced 
by vasodilators can be assessed and compares favorably with the 
microsphere standard. 
(J Am Coil Cardiol 1995;26:537-46) 
Collateral blood flow is important in the limitation of infarct 
size and preservation of regional myocardial function when 
critical coronary stenoses or occlusions develop (1-3). To date, 
coronary angiography has been the clinical reference standard 
for evaluating collateral blood flow. Unfortunately, this tech- 
nique has limited resolution, and the smallest vessels that can 
be visualized are >100 ~m in diameter (4). In addition, 
angiography provides only qualitative assessment of collateral 
blood flow. Kemper et al. (5) were the first to show that 
myocardial contrast echoeardlography could be used to visu- 
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alize myocardial perfusion through collateral f ow after coro- 
nary occlusion in animals. Subsequently, myocardial contrast 
echocardiography has been used to evaluate collateral blood 
flow in humans, even when these vessels are not well visualized 
angiographically (6-11). Detection of collateral flow by con- 
trast echocardiography in the setting of total vessel occlusion 
or a recent myocardial infarction relates to preservation of
myocardial function. In particular, contrast echocardiography 
is useful in predicting the recovery of function after coronary 
angioplasty of the infarct-related artery (11). However, the 
extent o which this technique can be used quantitatively has 
not been carefnlly examined because of the lack of an inde- 
pendent quantitative standard for measuring collateral f ow in 
humans. Accordingly, this investigation was designed, using an 
experimental nimal model of acute coronary thrombosis 
followed by reperfusion, to compare quantitative measure- 
ments of collateral blood flow by myocardial contrast echocar- 
diography with radiolabeled microspheres and to assess the 
relation between measurements of collateral flow by contrast 
echocardiography and the extent of ischemia nd recovery of 
function after reperfusion. 
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Methods 
Surgical preparation and instrumentation. This study was 
conducted in accordance with the "Guiding Principles of the 
American Physiological Society for the Use of Animals in 
Scientific Research." Male mongrel dogs were anesthetized 
with sodium pentobarbital, intubated and ventilated on a 
Harvard respirator. The dogs were placed supine, in the right 
lateral decubitus position. A modified 7F pigtail catheter was 
placed into the aortic root for injection of eehocardiographic 
contrast material. A left thoracotomy was performed through 
the fifth intercostal space, and the heart was suspended in a 
pericardial cradle. The left atrial appendage was cannulated. 
The proximal 2-cm segments of the left circumflex coronary 
artery and the left anterior descending coronary artery were 
isolated and instrumented with electromagnetic flow probes 
(model 501, Carolina Medical Electronics, Inc.). The left 
circumflex coronary artery was further instrumented with an 
intracoronary electrode distal to the flow probe but proximal to 
an adjustable screw ocduder (12,13). Arterial blood pressure 
(Statham P23 pressure transducer, Gould Inc.), electrocardio- 
graphic (ECG) limb lead II and coronary artery blood flow 
were continuously recorded on a polygraph (model 7, Grass 
Instrument Co.). 
Myocardial contrast eehocardiography. After instrumen- 
tation, the chest cavity was filled with warm saline solution, and 
a plastic Z!plock bag filled with warm, degassed water was 
placed over the heart o serve as an acoustic interface for the 
3.5-MHz echocardiographic transducer (Hewlett-Packard 
model 77020 AC). The transducer was positioned firmly in 
contact with the plastic bag through ultrasound gel. The 
mid-papillary muscle level was used as the short-axis cross 
section of interest. Myocardial contrast echocardiography was 
performed with commercially prepared sonicated 5% human 
serum albumin solution containing 4 x l0 s spheres/ml (Albu- 
nex) through amodified pigtail catheter. Albunex was injected 
with an ECG-monitoring R-wave-triggered power injector 
(Modified Mark IV, Medrad, Inc.). As with previous tudies, 
the dose of Albunex and the ultrasound system settings (i.e., 
acoustic power, reject, and gain) judged to show the optimal 
myocardial opacification at baseline for each dog were used 
and maintained constant for the remainder of the protocol 
(14,15). 
All echocardiographic contrast injections were recorded on 
0.5-in. VHS videotape. Beginning at least three frames before 
the injection of contrast and continuing until myocardial 
contrast effect had disappeared for several frames, end- 
diastolic frames were digitized on an off-line computer station 
(Microsonics 886 AT [16]). The digitized images were then 
analyzed with a custom-made videointensity program (16). 
Briefly, the short-axis cross section at the mid-papillary muscle 
level was divided into 12 equal sectors in a counterclockwise 
fashion, beginning with the anterior papillary muscle. The 
endocardial nd epicardial contours were manually drawn. A 
template was then created to enhance reproducibility when it 
was placed over subsequent frames. After all the images were 
analyzed, the computer subtracted the baseline background 
intensities in each segment from the contrasted images and 
created time-intensity curves from each of the segments. Area 
under the time-intensity curve was used as the contrast 
echocardiographic variable of myocardial perfusion (15,16). 
Experimen~l protocol. After completion of the surgical 
procedure, Albunex and radiolabeled microspheres were in- 
jected into the aortic root and left atrium, respectively, for 
baseline recordings. Thrombosis of the left circumflex coro- 
nary artery was induced by applying 109-/zA anodal direct 
current to the electrode. The current was discontinued 30 rain 
after the onset of thrombotic occlusion, which was defined as 
complete absence of blood flow recorded by the electromag- 
netic flow meter. Radiolabeled microspheres and echocardio- 
graphic ontrast were injected uring thrombosis. In nine dogs, 
adenosine was infused intravenously for 10 to 15 rain during 
thrombosis at a dose ranging from 154 to 465 txg/kg body 
weight per rain, adjusted to a maximal vasodilatory effect while 
maintaining systolic blood pressure >75 mm Hg. After return 
to baseline hemodynamie recordings, dipyridamole was admin- 
istered intravenously at a dose of 0.14 mg/kg per rain for 4 rain. 
Radiolabeled microspheres and echocardiographic contrast 
agent were injected uring infusion of each vasodilator at the 
peak of the hyperemic response observed with the electromag- 
netic flow meter in the nonischemic region. These drugs are 
knowu to alter collateral blood flow, and consequently they 
provided us with the opportunity to assess the sensitivity of 
myocardial contrast echocardiography for detecting changes in 
collateral flow. Hypotension was avoided durir, g adenosine 
administration to determine the effect of vasodilation i depen- 
dent of perfusion pressure. Adenosine has a short half-life 
(<2 s), allowing strict control of hemodynamic variables. No 
attempt was made to maintain systemic blood pressure during 
the administration f dipyridamole; the drug-induced hypoten- 
sion was expected to decrease collateral f ow. 
After the previously described measurements, the external 
screw occluder was slowly adjusted to the fully open position 
over 10 rain. If reperfusion did not occur spontaneously, 
thrombolysis was induced with recombinant tissue-type plas- 
minogen activator (rt-PA) (provided by Genentech, Inc.), 
0.6-ml~/kg intravenous bolus followed by 0.5 mg/kg intrave- 
nously over 30 rain. The bolus dose of rt-PA was repeated at 
the end of the 30-rain infusion if reperfusion had not occurred. 
Reperfusion was defined as the return of anterograde flow in 
the left circumflex coronary artery by electromagnetic flow 
probe. Time to reperfusion was defined as the time from initial 
opening of the external oecluder to the onset of anterograde 
flow. Radiolabeled mierosphere and echocardiographic con- 
trast injections were performed after 5 rain of stable reperfu- 
sion. lschemic time was defined as the time from thrombosis to 
the onset of reperfusion, including any time of rethrombosis 
before the experiment was ended. Reperfusion time was defined 
as the interval from onset of anterograde flow to the end of the 
experiment. 
Myocardial tissue processing. At the end of the reperfu- 
sion period, Evans blue (10 ml) was administered through the 
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left at.,um while an external occlusive ligature was applied to 
the left circumflex coronary artery at the site of thrombosis to 
determine in vivo the area perfused by the left circumflex 
coronary artery. The left circumflex coronary artery was dis- 
sected free and opened longitudinally, and the thrombus 
removed and weighed. The heart was weighed apd cut, parallel 
to the atrioventricular groove, transve~ely from apex to base 
in 1-cm sections, which were weighed and incubated in 1.5% 
triphenyltetrazolium chloride in 20 retool/liter of potassium 
phosphate (pH 7.4, 38°C). The area of infarcted myocardium 
was determined by planimetry as a percent of the area at risk 
and percent of the total left ventricle (17,18). Samples of 
myocardium were obtained from the mid-papillary muscle 
level, corresponding xvith the two-dimensional echocardio- 
graphic plane of interest. This entire 1-cm thick section was 
divided into 12 equal sectors in a counterclockwise fashion, 
beginning with the anterior papillary muscle (16). Each sector 
was weighed, placed in i0% buffered formalin, counted for 
radiolabeled microsphere detection and then processed for 
histologic evaluation. 
Regional myocardial blood flow. Radiolabeled micro- 
spheres were used as the standard for determining myocardial 
blood flow by the refer=nee withdrawal method (19). For each 
experiment, compatible microspheres (15 +- 3 /xm) were 
injected in a ra,'~.domized fashion at the designated time points 
(chromium-51, strontium-85, cerium-141, ruthenium-103, 
scandium-46, niobium-95). An aliquot of 1 to 2 million micro- 
spheres, diluted in warm saline solution (0.9%), was adminis- 
tered into the left atrium. Radioactivity levels of the tissue and 
blood samples were determined with a gamma spectrometer 
(LKB WaUae 1282 Compugamma, Pharmacia LKB). Regional 
myocardial blood flow was calculated by the formula Qm = 
Qr x Cm/Cr, where Qm = myocardial blood flow (ml/min); 
Qr = reference blood flow (mi/min); Cm = clam in myocardial 
sample; and C~ = cpm in reference blood sample. 
Eehocardiographie wall motion analysis. All echocardio- 
graphic images were recorded on 0,5-in. VHS tape and played 
back for the analysis of wall motion. Radial shortening fraction 
was obtained with a Digisonics ystem (Cardiology Version, 
package quipped with internal calipers) in the 12 radii into 
which the short-axis view was divided to match the sectors used 
for myocardial contrast echocardiography and radiolabeled 
microsphere analyses. As in previous tudies (16), a floating 
epicardial centroid was used to measure radial shortening 
fraction. 
Histopathologic examination. Sectors corresponding tothe 
echocardiographic plane of interest were placed in 10% buff- 
ered formalin and processed routinely for light microscopic 
examination. Hematoxylin and eosit~-stained sections of the 
myocardium were reviewed and scored (0 to 4+) for evidence 
of necrosis and extent of neutrophil infiltration (20). The 
scores for necrosis were based primarily on the extent of 
contraction band necrosis seen in myocytes (myocytolysis). 
Neutrophil infiltration was described as being within the 
vasculature (margination) or having migrated across the vas- 
cular endothelium into the myocardium (infiltration). 
Statistical analysis. Two groups of animals were estab- 
lished on the basis of the presence or absence of collateral f ow 
detected by contrast echocardiography (defined as the pres- 
ence of a time-intensity curve in the ischemic region during 
thrombosis). Results are expressed as mean value +_. SEM. 
Differences among groups were analyzed using analysis of 
variance, attd a Newman-Keuls multiple comparison test was 
used to determine which mean values were significantly differ- 
ent. For analysis purposes, four time sequences were estab- 
lished: baseline, thrombos~s, vasodilator challenge (combining 
adenosine and dipyridamole) and reperfusion. Time- 
dependent changes within groups were determined by 
repeated-measures analysis of variance. If a significant inter- 
action was present, aBonferroni multiple comparison method 
was used to determine the time period(s) at which the group 
means differed significantly. If the time factor main effect was 
significant, a Newman-Keuls multiple comparison test was 
used to determine which mean values were significantly differ- 
ent. Myocardial contrast echocardiographic data and radiola- 
beled microsphere data were analyzed as actual data and as the 
ratio of ischemic to nonischemic myocardium to correct for 
variability among injections. Linear regression analyses were 
performed to determine the relation between 1) myocardial 
blood flow determined by radiolabeled microsph~,res and area 
under the time-intensity curve of contrast echocardiography; 
2) histopathologic changes and myocardial perfusion studies; 
and 3) area under the time-intensity curve of contrast echo- 
cardiography and radiolabeled microspheres and regional wall 
motion (percent fractional shortening) during thrombosis. 
Linear regression analysis was also performed to determine the 
relations between infarct size and duration of ischemia in the 
two groups of animals. Chi-square analysis was used to deter- 
mine concordance between myocardial contrast echocardiog- 
raphy and radiolabeled microspheres for identification of 
collateral flow during ischemic onditions and distinction as to 
the magnitude of collateral flow (above and below a cutoff 
point); p <- 0.05 was considered significant. 
Results 
Group characteristics. Thirty-six dogs underwent instru- 
mentation, and 23 completed tile protocol. Thirteen animals 
were excluded from data analysis for the following reasons: 
technical difficulties (surgical and instrumentation,  = 4; 
intractable ventricular fibrillation after thrombosis, more than 
three defibrillations, n = 3), failure to reperfuse (n = 1), 
intractable hypotension aft~:r intravenous dipyridamole infu- 
sion during thrombosis (n = 4), microemboli causing uninter- 
pretable contrast echocardiographic mage.3 (n = 1). The 
animals were separated into two groups on the basis of 
recognition by contrast echocardiography of perfusion in the 
ischemic region during thrombosis: presence (n = 13) or 
absence of collateral flow (n = 10) (Fig. 1 and 2). Eight dogs 
had spontaneous reperf~:sion a d thus did not receive rt-PA. 
The nine dogs given vasodilators were randomly selected and 
included five in the group with and four in the group without 
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Figure 1. Myocardial contrast echocardio- 
graphic images from representative dogs with- 
out collateral f ow. A, Short-axis view at mid- 
papillary muscle level before echo contrast 
injection. B, Baseline homogeneous effect after 
echo contrast injection. C, Absolute contrast 
perfusion defect (arrows) in the territory of the 
thrombosed left circumflex coronary artery. D, 
Improved perfusion of defect after eperfusion. 
collateral f ow detected by myocardial contrast echocardiogra- 
phy. 
Comparison of dogs with and without collateral flow by 
myocardial contrast echocardiography showed similar body 
weight (21.0 _+ 1.5 vs. 23.6 + 1.5 kg, respectively), postmortem 
heart weight (171 _ 11 vs. 174 +_ 1~ g, respectively) and area 
perfused by the left circumflex coronary artery, expressed as 
percent of left ventricle (35 _+ 2% vs. 41 _ 2%, respectively). 
Infarct size was smaller (infarct size/area t risk: 11 ___ 4% vs. 
26 _ 6% [p = 0.06]; 4 _ 1% vs. 11 +_ 3% [p = 0.05], 
respectively) in dogs with than without collateral f ow. Infarct 
size ~as not related to duration of ischemia in dogs with 
collateral flow, but a significant direct relation was found in 
those without collateral f ow (p = 0.01, r = 0.73). Duration of 
ischemia nd reperfusion were similar in the groups with or 
without collateral flow as detected by myocardial contrast 
echocardiography (ischemia 122 _ 20 vs. 138 +__ 34 rain; 
reperfusion 53 _+ 8 vs. 70 _+ !9 rain, respectively). 
Hemod~amic varXables. Initial recordings of heart rate 
and mean arterial pressure did not differ between groups 
(Table 1). Heart rate tended to be slower in dogs with 
collateral flow by myocardial contrast echocardiography, but 
this difference was not significant. There was a decrease in 
heart rate in both groups over time, especially when intrave- 
Figure 2. Myocardial contrast echocardio- 
graphic images from representative dogs with 
collateral flow. A, Short-axis view at mid- 
papillary muscle level before echo contrast 
injection. B, Baseline homogeneous effect af- 
ter echo contrast injection. C, Relative con- 
trast perfusion defect (solid arrows) in the 
territory of the thrombosed left circumflex 
coronary artery; any contrast effect seen in 
this territory is made possible by collateral 
blood flow (open arrows). D, Improved per- 
fusion of defect after reperfusion. 
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Table 1. Hemodynamic Variables (mean ± 5~M) 
Baseline Thrombosis Vasodilator Repcrfusion 
Heart rate (beats/min)* 
Collateral flow 110 _+. 6 109 ± 5 91 +_ 97 109 ± 6 
No collateral flow 120 ± 5 118 +_ 5 1!0 ± 10 109 _± ~.-~ 
Mean arterial pressure (ram Hg)§ 
Collateral flow 103 ± 5 89 "" 5 83 ± 9:1: 87 ± 8 
No collateral flow 102 ± 51 82 ± 5 78 ± 8 76 .- 8 
LCx blood flow (ml/min)§ 
Collateral flow 40 -+ 3 0ll 011 38 ± 8 
No collateral flow 41 ± 7 0ll 0l[ 37 ± 10 
LAD blood flow (ml/min)* 
Collateral flow 23 ± 2 26 ± 3 60 ± 9i" 38 ± 7 
No collateral flow 26 +-. 3 39 --. 6 64 ± 8t 34 ± 6 
Eehoeardiographic radial 
shortening fraction (%) 
Anterior 
Collateral flow 37 ~" 4 34 ± 4 41 _ 10 38 ± 6 
No collateral flow 35 ± 2 27 - 8 46 ± 5 35 ± 4 
Posterior 
Collateral flow* 33 + 4 14 - 511 3 ± 411 27 ± 6 
No collateral flow§ 28 ± 5~" 2 --+ 3 -1 - 1 6 ± 3¶ 
*Change over time within group, p < 0.05. tDitterent from all other time points, p < 0.05. :~Diffcrent from baseline, 
p < 0.05. §Change over time within g~'oup,  < 0.0001. I[Different from baselin~ and reperfusion, p < 0.05. ¶Shortening 
fraction less in dogs without han th¢Jse with collateral f ow on reperfusion, p < 0.05, LAD = left anterior descending 
coronary artery; LCx = left circumfi/ex coronary artery. 
f 
nous vasodilators were administered. Likewise, mean arterial 
pressure decreased over time in both group',; (p < 0.0001), but 
the difference between groups was not significant. 
At baseline, left circumflex and left anterior descending 
coronary artery blood flow did not differ between groups. Left 
circumflex coronary artery blood flow decreased precipitously 
in both groups e,s thrombosis occurred. ~kfter eperfusion, left 
circumflex coronary artery blood flow returned to baseline 
levels in both groups. Left anterior descending coronary artery 
blood flow tended to be higher during isehemia in dogs without 
than with collateral flow. Blood flaw in the left anterior 
descending coronary artery increasf;d in both groups during 
the vasodilator challenge, but there was no difference between 
groups at any time. 
The time required for permanent thrombotic occlusion of 
the left circumflex coronary artely to occur was similar in the 
groups with or without coilatere.l f ow by myocardial contrast 
echocardiography (81 +_. 12 vs. ~J3 ± 11 rain, respectively), and 
thrombolysis was induced with/similar doses of rt-PA (0.65 ± 
0.13-mg/kg bolus and 0.48 _+/0.06 mg/kg intravenously over 
30 min, n = 8 vs. 0.66 _+: 0.17 :ng/kg bolus and 0.46 ± 
0.04 mg/kg intravenously over 30 rain, n = 7, respectively) and 
over a similar period of time (20 _ 4 min). Postmortem 
dissection of the left circumflex coronary artery performed at 
the end of the protocol confirmed the presence of occlusive 
thrombus in 2 dogs with rethrombosis and negligible or small 
nonocclusive thrombi n the remaining 21. 
Regional myocardial blood flow and perfusion by contrast 
echocardiography. Myocardial blood flow detected by radio- 
labeled microspheres in the anterior nonischemic myocardium 
did not change over the course of the protocol in either group, 
except for a significant increase during administration of the 
vasodilators (p < 0.005). Myocardial blood flow in the poste- 
rior isehemic myocardium changed significantly over the 
course of the protocol in both groups (Fig. 3). During throm- 
bosis, flow to the ischemic myocardium was significantly lower 
(p < 0.005) in dogs without (0.17 _ 0.02 ml/min per g) than 
those with collateral flow (0.45 _+ 0.06 ml/min per g) by 
myocardial contrast echocardiography. In the five dogs with 
collateral flow and administration of vasodilators, myocardial 
perfusion to the ischemic area decreased significantly (0.39 ± 
0.08 to 0.25 _+ 0.06 m!/min per g, p < 0.05). 
Myocardial blood flow detected by contrast echocardiogra- 
phy paralleled the results observed with radiolabeled micro- 
spheres (Fig. 3). The difference in the area under the curve 
between groups during thrombosis was defined by study de- 
sign. During vasodilator challenge, the area under the curve 
decreased significantly (65 ± 22 to 22 _+ 5 intensity units, p < 
0.05) in the five dogs with collateral flow. Although radiola 
beled microspheres and contrast echocardiography gave direc- 
tionally similar results durit~g thrombosis, the correlation be- 
tween the two was poor (r = 0.41, p = 0.003). Nevertheless, the 
two techniques had a 91% agreement in identification of 
collateral flow >0.3 ml/min per g (p < 0.0001), with only 2 of 
23 studies classified ifferently. 
Better correlation (r = 0.72, p = 0.0001) between myocar- 
dial contrast echocardiography and radiolabeled microspheres 
was observed when the ratio of ischemic to nonischemic 
transmural myocardial blood flow was analyzed (Fig. 4). Esti- 
mates of this ratio by contrast echocardiography on an indi- 
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Figure 3. Assessment of perfusion in the posterior ischemic myocar- 
dium by radiolabeled microspheres (top) and contrast echocardiogra- 
phy (bottom). Perfusion decreased in each group during thrombosis; 
thus, the change over the course of the protocol in both groups was 
significant (p < 0.005). Blood flow to the isehemic myocardium wa~ 
lower in dogs without collateral flow (solid circles) during thrombosis 
(*p < 0.005). The difference in area under the curve observed between 
groups during thrombosis was defined by study design. In dogs with 
collateral flow (open circles), administration of vasodilators produced 
a further decrease in myocardial blood flow to the ischemic area ('~p < 
0.05), to values that were not different from dogs without collateral 
flow. The decrease in collateral flow induced by vasodilators was also 
detected by contrast echocardiography (tp = 0.05). 
vidual basis was limited by the wide scatter of ,~.le data. 
However, by using this ratio it was possible to distinguish 
collateral perfusion with a ratio >0.3 from that with a ratio 
-<0.3, with 75% agreement with radiolabeled microspheres 
(p < 0.001) (Fig. 5). Likewise, it was possible to distinguish 
collateral flow with a perfusion ratio >0.5 from that with a 
ratio ---0.5, with 88% agreement with radiolabeled micro- 
spheres (p < 0.0001). The effect of vasodiiation on collateral 
blood flow was pronounced when the ratio of ischemic to 
O 
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Figure 4. Ratio of ischemie to nonischemic transmural myocardial 
perfusion: comparison of radiolabeled microspheres with contrast 
echocardiography. During thrombosis, the ratio of ischemie to nonisch- 
emic myocardial perfusion assessed by the area under the curve of 
contrast echocardiography correlated significantly to the ratio of 
ischemic to nonisehemic myocardial blood flow by radiolabeled micro- 
spheres (p = 0.0001). 
nonischemic transmural myocardial blood flow was analyzed 
(Fig. 6). All dogs experienced a considerable decrease in 
collateral perfusion with adenosine and dipyridamole admin- 
istration, whether assessed by microspheres or by contrast 
echocardiography. 
Regional myocardial function. Echocardiographically de- 
termined radial shortening fractions obtained in the anterior 
nonischemic myocardium were similar in the two groups at atl 
Figure 5. Comparison of radiolabeled microsphere ratios, above or 
below a cutoff level, with ratios detected by contrast echocardiography. 
From the ratio of ischemic to nonischemic transmural myocardial 
perfusion, it was possible to distinguish collateral perfusion with a ratio 
>0.3 from that with a ratio <0.3, with 75% agreement with radiola- 
beled mierospheres, and it was possible to distinguish collateral flow 
with a perfusion ratio >0.5 from that with a ratio <-0.5, with 88% 
agreement with radiolabeled microsphercs, 
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Figure 6. Individual response ofcollateral flow to vasodilators: atio of 
ischemic to nonisehemic transmural myocardial perfusion. During 
thrombosis, the ratio of ischemie to nonischemic myocardial perfusion 
assessed by either adiolabeled mierospheres (top) or the area under 
the curve of contrast eehocardiography (bottom) decreased signifi- 
cantly during adenosine ordipyridamole administration (*p < 0.05). 
time points and did not change significantly in either group 
over time (Table 1). Radial shortening fractions obtained in 
the posterior ischemic myocardium were similar in the two 
groups at baseline but changed significantly in both groups 
over time. There was a trend toward a greater eduction in 
shortening fraction when no collateral flow were seen. Further- 
more, during thrombosis, the ratio of ischemic to ,=.onischemic 
peffusion determined with either myocardial contrast echocar- 
diography (p = 0.0002, r = 0.67) or radiolabeled microsphercs 
(p = t)O001, r = 0.89) correlated significantly with regional 
shortening fraction (Fig. 7). In addition, the group with 
collateral flow experienced rapid recovery of function after 
repeffusion, whereas the group without collateral flow re- 
mained with significant hypokinesia in the ischemic region 
(p < 0.05). 
Histopathologic scores. Histopathologic s ores correlated 
inversely with the ratio of ischemie to nonischemic perfusion 
detected by contrast ee.hocardiography (p = 0.0001, r = 0.59), 
as it did with the radiolobeled microsphere detection of blood 
flow during ischemia in the individual samples (p = 0.0001, r = 
0.48). Likewise, the histopa~hologic and neutrophil nfiltration 
scores were lower in the group with than without collateral 
flow by contrast echocardiography (Table 2). 
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Figure 7. Relation of ischemic *.o nonischemic perfusion ratio and 
radial shortening fraction. The ratio of ischemic to nonisehemic 
myocardial perfusion measured by area under the curve (tap) (p = 
0.0002) or radiolabeled microspheres (bottom) (p < 0.000l) t~orrelated 
well with radial shortening fraction in the ischemic region during 
thrombosis. 
Discuss ion  
Collateral blood flow has a protective ffect on areas of 
ischemic myocardium, particularly during acute coronary 
thrombosis. The greater the collateral flow to the ischemic 
myocardium, the smaUer the region of dysfunction and the 
area of infarction (1-3,10,21--23) and the greater the improve- 
ment in regional eft ventricular rune:ion after relief of the 
coronary occlusion (11). To date, a diverse number of tech- 
niques, such as electrocardiographic monitoring (24), cardiac 
catheterization (8,10), enzymatic analysis (3), radioisotope 
perfusion studies (25,26) and myocardial contrast eehocardi- 
ography (27), have been used in attempts o define the value of 
collateral flow in limiting the extent of ischemic injury. 
Collateral perfusion in experimental models. In the 
present study, myocardial contrast echocardiography was 
shown to be capable of detecting collateral flow to an ischemic 
area during coronary thrombosis. On repeffusion, the ischemic 
myocardium with collateral flow had faster and more complete 
recovery of function and smaller histochemicaily detected area 
of necrosis than the myocardium without collateral flow. In 
experiments where collateral blood flow was seen during 
myocardial contrast echocardiography, blood flow detected by 
radiolabeled microspheres was higher, whereas histopatho- 
logic and neutrophil infiltration scores were lower, than when 
no collateral blood flow was seen. These differences could not 
be explained on the basis of hemodynamic variables, area of 
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Table 2. Myocardial B ood Flow (radiolabeled microspheres) and Histopathologic Scores (mean +_ SEM) 
Myocardial Blood Flow 
Tissue Type Thrombosis* Reperfusion Histologic* 
(no of samples) (ml/min per g) (ml/min per g) Score 
Neutrophil* 
Margination Infiltration 
lschemic (70) 0.23 ± 0.03 0.95 ± 0.12 1.9 ± 0.10 1.23 -+ 0.09 0.81 ± 0.10 
Collateral f ow (33) 0.37 ± 0.05 0.90 ± 0.17 1.4 ± 0.10 1.00 ± 0.08 0.48 __. 0.10 
No collateral f ow (37) 0.10 ± 0.¢~2 0.94 ± 0.18 2.3 ± 0.21 1.40 ± 0.10 1.10 ± 0.25 
Nonischeraic (47) 0.89 ± 0.07 0.88 ± 0.06 0.6 ± 0.10 0.46 ± 0.11 0.06 ± 0.04 
*lschemic versus nonischemic perfusion, p = 0.0001; collateral flow versus no collateral flow, p < 0.05. 
myocardium at risk, total ischemic time, duration of reperfu- 
sion, reperfusion blood flow or thrombolytic efficacy. Thus, 
myocardial contrast echocardiography was able to identify. 
physiologically significant collateral flow that limited the de- 
gree of ischemic damage during coronary thrombosis, thereby 
enhancing the functional recovery of myocardium on reperfu- 
sion. 
Despite major differences in the animal models used, our 
data parallel the results previously reported by Bolli et al. (28), 
who found that the single most important factor determining 
the recovery of myocardial function after a 15-min coronary 
occlusion and reperfusion was the degree of collateral flow. 
Our study used a un.~que model of prolonged (>30 min) 
thrombotic occlusion with reperfusion i duced by thrombolysis 
to mimic closer the clinical setting of myocardial infarction. 
We found that dogs with detectable collateral flow to the 
ischemic region during thrombosis demonstrated significantly 
better ecovery of function than those without collateral f ow. 
Furthermore, a significant relation was observed between 
fractional shortening inthe ischemic region during thrombosis 
and the magnitude of collateral perfusion by contrast echocar- 
diography. All of these findings highlight he value of myocar- 
dial contrast echocardiography in detecting physiologically 
important collateral f ow. 
Previous studies (9-11,27) have demonstrated the func- 
tional significance of collateral flow detection by myocardial 
contrast echocardiegraphy in both the experimental and clin- 
ical setting. Our findings in this regard are therefore confirma- 
tory. However, our study is unique for using a model of 
thrombotic occlusion and reperfusion to determine the sensi- 
tivity of contrast echocardiography in detecting collateral f ow 
and its accuracy in determining changes in collateral perfusion 
induced by hemodynamic alterations. Our findings uggest that 
the level of collateral perfusion that can be visualized with 
contrast eehocardiography is between 0.22 and 0.30 ml/min 
per g. With the latter value, the concordance b tween myocar- 
dial contrast echocardiography and radiolabeled microspheres 
was 91%, with only 2 of 23 studies classified ifferently. The 
use of an ischemic to nonischemic ratio of area under the 
time-intensity curve allowed distinction between levels of 
collateral flow, although with some degree of scatter in the 
results. Furthermore, contrast echocardiography detected the 
decrease incollateral perfusion that occurred uring vasodila- 
tor challenge, with excellent agreement with the microsphere 
standard. 
A limited number of studies have examined the minimal 
level of coUateral blood flow needed to preserve myocardium 
during coronary occlusion. Shen et al. (29) used dogs with 
permanent left circumflex coronary artery occlusion and mea- 
sured myocardial collateral blood flow with radioiabeled mi- 
crospheres over time. They found few tissue samples with 
evidence of infarction that had blood flow >0.3 mi/min per g, 
even after a 1-h coronary occlusion. Although we used a 
different model with varying durations of ischemia nd reper- 
fusion, the majority of collateral f ow detected by myocardial 
contrast echocardiography was >0.30 mi/min per g, and this 
level of collateral perfusion appeared to limit the extent of 
infarction. 
Several key investigations have paved the way for applica- 
tion of myocardial contrast echocardiography in the evaluation 
of collateral flow. In their original description of collateral f ow 
visualization by contrast echocardiography, Kemper et al. (5) 
compared collateral flow by radiolabeled microspheres with 
the appearance time and peak intensity of myocardial contrast 
in a canine model of permanent left circumflex coronary artery 
occlusion. Although there was variability among dogs with 
regard to collateral blood flow, collateral flow tended to 
increase over time, as seen in other studies (29). Likewise, 
peak intensity of contrast in the ischemic myocardium in- 
creased over time. Kaul et al. (27) used myocardial contrast 
echocardiography to quantitate the ischemic territory in a 
canine model of permanent left circumflex coronary artery 
occlusion under several conditions of left anterior descending 
coronary artery perfusion. Increasing collateral flow by raising 
left anterior descending coronary artery perfusion pressure 
decreased the area at risk, increased transmural b ood flow and 
improved myocardial function in the ischemic territory. Low- 
ering left anterior descending coronary artery perfusion pres- 
sure had the opposite effect. The deleterious response of 
collateral f ow to the uncontrolled administration f vasodila- 
tors seen in our study supports these findings, suggesting that 
coronary perfusion pressure is of utmost importance in the 
preservation fcollateral f ow. 
Collateral perfusion in humans. In the clinical setting, 
several studies (6-11) have been pivotal in the evolution of 
contrast echocardiography for detection of collateral perfu- 
sion. Spotnitz et al. (7) intraoperatively studied patients with 
severe left anterior descending coronary artery disease under- 
going coronary artery bypass grafting. Collateral blood flow to 
the anterior ten'itory, assessed by video intensity, improved 
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after placement of a graft in the posterior descending artery 
despite the absence of demonstrable collaterals during preop- 
erative coronary arteriography in 50% of the patients. Grill et 
al. (9) used contrast echocardiography to assess collateral f ow 
in patients undergoing coronary angioplasty. Before angio- 
plasty, patients with angiographic collateral flow (50% of the 
group) had a larger myocardial area of collateral perfusion 
detected by contrast echocardiography t at decreased signifi- 
cantly after successful angioplasty. Though the extent of myo- 
cardium receiving collateral flow was quantified, the actual 
flow rate was not measured. In a small group of patients with 
a previous anteroseptal or inferior infarction and angiographi- 
tally detected collateral flow, Lira et al. (8) studied the 
presence of collateral flow by contrast echocardiography. Peak 
background-subtracted gray level was measured in the infarct 
and control regions. No contrast enhancement was seen with 
injection of the infarct-related artery. Contrast injection into 
the artery providing collateral f ow caused enhancement i  1 of 
8 patients with poor collaterals, 9 of 10 with moderate col- 
lateral flow, and 9 of 11 with good collateral flow. 
Peak background-subtracted graylevel in the infarcted region 
was lower in akinetic or dyskinetic segments than in hypoki- 
netic (p < 0.05) or normal segments (p < 0.01). The relation 
between collateral perfusion and regional wall motion was 
better with contrast echocardiography t an with angiography. 
Sabia et al. (10,11) also showed that successful coronary 
angioplasty after myocardial infarction results in disappear- 
ance of collateral flow as assessed by myocardial contrast 
echocardiography. Likewise, they observed that the anglo- 
graphic detection of collateral flow correlated poorly with 
regional wall motion, whereas detection of collateral perfusion 
by myocardial contrast echocardiography related well with the 
severity of regional dysfunction. Furthermore, Sabia et al. 
showed that collateral flow detected by myocardial contrast 
echocardiography predicts recovery of function after angio- 
plasty despite prolonged occlusion of the infarct-related artery. 
They observed, as did we in the present study, a lack of 
correlation between regional function and duration of coro- 
nary occlusion in the presence of adequate collateral perfu- 
sion. 
General limitations. ?dthough the findings in this and 
previous investigations support he value of myocardial con- 
trast echocardiography as a quantitative technique for the 
evaluation of collateral flow, comparison of results with mea- 
surements of flow by radiolabeled microspheres indicates that 
the technique isnot as precise as one would like and provides 
at best an estimate of the magnitude of collateral perfusion. 
However, this estimate appears accurate in tracking directional 
changes in collateral flow induced by interventions. These 
results are not surprising because most of the studies in 
myocardial perfusion with contrast echocardiography ave 
foun4 similar limitations in flow quantitation (15,16,30). Fac- 
tors that limit the accuracy of the technique have been 
discussed previously (31-33) and include dependency of the 
time-intensity curve on both myocardial blood volume and 
flow, absence of an input function, variability of the time- 
intensi~ curve observed on repeated injections and technical 
factors inherent to ultrasound (i.e., attenuation, gray-scale 
compression algorithms used by commercial systems, among 
others). It is conceivable that some of the factors limiting 
quantitation of myocardial perfusion with contrast echocardi- 
ography may cause greater errors at the two extremes of flow 
states, and this could explain, in part, the improvement ob- 
served when the data are expressed as a ratio of ischemic to 
nonischemic regions. 
Limitations of this study. Because of our attempt to use a 
clinically relevant model of coronary thrombosis foUowed by 
thrombolysis and reperfusion, several variables (duration of 
ischemia, time to reperfusion and duration of reperfusion) 
could not be controlled as well as one could in a standard 
occlusion-reperfusion model. Nevertheless, none of these vari- 
ables appeared to influence the differences observed between 
dogs with and without collateral flow detected by contrast 
echocardiography. Furthermore, our findings may offer some 
insight into the clinical scenario in which these variables are 
also poorly standardized. Perhaps amore important limitation 
of this study is the use of an epen-chest rather than a 
closed-chest animal model. This was done to facilitate the 
acquisition of the echocardiographic images in a fixed short- 
axis plane that matched segment by segment the areas ubse- 
quently studied with radiolabeled microspheres, histochemical 
staining and histologic evaluation. The disadvantage of such an 
approach, however, is that we could not assess the longitudinal 
distribution and magnitude of the collateral perfusion or the 
wall motion abnormalities during thrombosis and reperfusion. 
Summary. Myocardial contrast echocardiography identi- 
fies physiologically significant collateral flow capable of limit- 
ing the extent of ischemic injury during coronary thrombosis 
and enhancing functional recovery after reperfusion. In the 
present study we demonstrated that contrast echocardiography 
compares favorably with radiolabeled microspheres inestimat- 
ing the magnitude of collateral f ow during coronary thrombo- 
sis. Measuring the area under the time-intensity curve and 
using the ratio of areas in the ischemic and nonischemic 
regions allow differentiation between grades of collateral flow 
and, importantly, provide a measurement that can be used to 
quantitate changes in collateral perfusion. These findings, 
coupled with recent clinical studies, leave little doubt as to the 
value of myocardial contrast echocardiography as a clinical 
tool to assess collateral flow in humans. 
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